Movement Disorders Journal Podcasts 2012-2015
Unknown
Add to My Podcasts
Episodes
About
Reviews
Charts
Promote
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
2 minutes
Posted Nov 10, 2015 at 9:27 am.
0:00
2:32
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Previous
Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD
Next
A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease
← See all 577 episodes of Movement Disorders Journal Podcasts 2012-2015
Privacy Manager
